The global biomedical refrigerator and freezer industry is poised for steady growth, with an estimated valuation of USD 3,510.65 million in 2024 and projected to reach USD 6,053.8 million by 2034. This expansion reflects a compound annual growth rate (CAGR) of 5.6% over the forecast period.
The market’s growth is driven by the increasing demand for temperature-sensitive storage solutions across hospitals, research laboratories, and biopharmaceutical companies. Biomedical refrigerators and freezers are crucial for preserving vaccines, blood samples, and other critical medical materials, ensuring their efficacy and safety.
Advancements in refrigeration technology, coupled with stringent storage requirements for emerging biologics and specialized medicines, are further propelling market expansion. Additionally, the growing global focus on healthcare infrastructure development and the rising prevalence of chronic diseases contribute to the rising demand.
A Full Report Overview – https://www.futuremarketinsights.com/reports/global-biomedical-refrigerators-freezers-market
Key Takeaways:
- The biomedical refrigerator and freezer market is expected to grow at a 5.6% CAGR, reaching $6.1 billion by 2034.
- Increased need for temperature-controlled storage drives demand across healthcare and research sectors.
- Technological advancements in refrigeration enhance product reliability and efficiency.
- Rising healthcare infrastructure investments and chronic disease management bolster market growth.
Market Drivers
- Rise of Biobanking and Cryopreservation: The increasing demand for biobanking and cryopreservation techniques is driving the need for advanced refrigeration solutions to store biological samples safely.
- Growing Prevalence of Chronic Diseases: The rising incidence of chronic illnesses necessitates effective storage solutions for vaccines and biological materials, further boosting market growth.
- Technological Advancements: Innovations in biomedical refrigeration technology are enhancing the efficiency and reliability of these systems, making them more appealing to healthcare providers.
- Regulatory Requirements: Stringent regulations regarding the storage of temperature-sensitive materials in healthcare and pharmaceutical sectors are increasing the adoption of biomedical refrigerators and freezers.
Regional Insights
- The market is expected to see significant growth in regions with increasing healthcare investments, particularly in countries like China, which is projected to have a high CAGR through 2034.
Competitive Landscape
The biomedical freezer and refrigerator market is marked by an active rivalry between existing industry leaders, emerging competitors, and innovators with a specific focus on a specialty. Important players in the market employ strict tactics to get a competitive edge in a field characterized by regulatory compliance, technical innovation, and changing consumer needs.
Using their vast R&D resources and global reach, industry leaders, including Helmer Scientific, Haier Biomedical, and Thermo Fisher Scientific Inc., control a significant portion of the market.
Recent Developments
- In October 2023, Haier Biomedical introduced a new range of energy-saving TwinCool frequency conversion ULT freezers for pharmaceutical, clinical research, and public health laboratories. This sample storage system includes numerous unique technologies, including frequency conversion compressors for low power consumption and a dual refrigeration system, to keep samples safe and secure while minimizing environmental effects.
- In February 2023, PHC Corporation of North America, a supplier of the PHCbi brand of cell preservation and growth products in North and Latin American markets, released the PHCbi brand VIP ECO® SMART ultra-low temperature freezer series for use in medical institutions, universities, and pharmaceutical businesses.
Competitive Landscape
The biomedical freezer and refrigerator market is marked by an active rivalry between existing industry leaders, emerging competitors, and innovators with a specific focus on a specialty. Important players in the market employ strict tactics to get a competitive edge in a field characterized by regulatory compliance, technical innovation, and changing consumer needs.
Using their vast R&D resources and global reach, industry leaders, including Helmer Scientific, Haier Biomedical, and Thermo Fisher Scientific Inc., control a significant portion of the market.
Recent Developments
- In October 2023, Haier Biomedical introduced a new range of energy-saving TwinCool frequency conversion ULT freezers for pharmaceutical, clinical research, and public health laboratories. This sample storage system includes numerous unique technologies, including frequency conversion compressors for low power consumption and a dual refrigeration system, to keep samples safe and secure while minimizing environmental effects.
- In February 2023, PHC Corporation of North America, a supplier of the PHCbi brand of cell preservation and growth products in North and Latin American markets, released the PHCbi brand VIP ECO® SMART ultra-low temperature freezer series for use in medical institutions, universities, and pharmaceutical businesses.
Key Players in the Biomedical Refrigerator and Freezer Market
- Thermo Fisher Scientific Inc.
- Haier Biomedical
- Helmer Scientific
- Eppendorf AG
- Panasonic Healthcare Co., Ltd.
- PHC Holdings Corporation
- B Medical Systems S.à r.l.
- Liebherr Group
- Terumo Corporation
- Labcold Ltd.
- ARCTIKO A/S
- Follett LLC
- Vestfrost Solutions
- EVERmed S.r.l.
- Accucold by Summit Appliance
- LEC Medical
- Stirling Ultracold
- Froilabo
- Bionics Scientific Technologies (P) Ltd.
- Fiocchetti
Biomedical Refrigerator and Freezer Market Segmentation
By Product:
- Blood Bank Refrigerators
- Lab Refrigerators
- Lab Freezers
- Plasma Freezers
- Shock Freezers
- Ultra-low Temperature Freezers
By End User:
- Hospitals
- Research Laboratories
- Pharmaceutical and Biotechnology Companies
- Blood Banks
- Diagnostic Centers
- Pharmacies
- Biobanks
- Academic and Research Institutes
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- Asia Pacific (APAC)
- Middle East & Africa (MEA)
- Japan
Explore FMI’s Related Ongoing Coverage on Healthcare Market Insights Domain:
Cell and Gene Therapy Clinical Trial Market
Hypophospatasia Treatment Market
Air Ambulance Services Market
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube